Herceptin 600mg Injection (Trastuzumab) – Complete Product Description

Herceptin 600mg Injection (Trastuzumab) is a prescription oncology medicine manufactured by Roche and used as a targeted treatment for selected HER2-positive cancers. The active ingredient, trastuzumab, is a recombinant humanized monoclonal antibody that specifically targets the HER2 (human epidermal growth factor receptor 2) protein found in certain cancer cells.

HER2-positive cancers can contain abnormally high levels of HER2 receptors, which can contribute to cancer-cell growth and survival. Trastuzumab binds to HER2 and interferes with HER2-mediated signaling, helping slow the growth and spread of HER2-positive cancer cells. It can also activate immune mechanisms that help the body identify and destroy HER2-expressing cells.

Herceptin 600mg is supplied as a ready-to-use solution for subcutaneous injection and is administered by a qualified healthcare professional. The product listed here is manufactured by Roche and supplied in a pack size of 1 injection.

Herceptin 600mg Injection – Product Information

Brand Name: Herceptin
Active Ingredient: Trastuzumab
Strength: 600mg
Dosage Form: Solution for subcutaneous injection
Route of Administration: Subcutaneous (SC) injection
Manufacturer: Roche
Pack Size: 1 injection
Drug Class: HER2-targeted monoclonal antibody
Therapeutic Class: Antineoplastic / Targeted cancer therapy
Prescription Status: Prescription medicine

Unlike the intravenous Herceptin formulation, the 600mg presentation is administered subcutaneously, according to the approved product instructions. It should only be administered by an appropriately trained healthcare professional.

What Is Herceptin 600mg Injection Used For?

Herceptin (Trastuzumab) is used for selected patients with HER2-positive breast cancer and other approved HER2-positive malignancies, depending on the applicable treatment indication.

It may be prescribed for:

• HER2-positive early breast cancer
• HER2-positive locally advanced breast cancer
• HER2-positive metastatic breast cancer
• Certain other approved HER2-positive cancer indications

Treatment may be given alone or together with chemotherapy, endocrine therapy or other cancer medicines depending on the patient’s diagnosis and treatment plan.

Herceptin 600mg for HER2-Positive Breast Cancer

Herceptin is an important targeted therapy for patients with HER2-positive breast cancer.

HER2 testing is performed to determine whether the cancer has HER2 overexpression or amplification. Patients with confirmed HER2-positive disease may be considered for trastuzumab-based treatment.

Depending on the stage of breast cancer, Herceptin may be incorporated into treatment before surgery, after surgery or for advanced/metastatic disease.

Herceptin for Early Breast Cancer

For appropriately selected patients with HER2-positive early breast cancer, trastuzumab may be used as part of a treatment program that can include surgery, chemotherapy, radiation therapy or other systemic treatments.

The exact treatment sequence depends on the patient’s diagnosis and the oncologist’s treatment plan.

Herceptin for Metastatic Breast Cancer

Herceptin may be used for HER2-positive metastatic breast cancer. Depending on previous treatment and the clinical situation, trastuzumab may be combined with other anticancer medicines.

The oncologist determines the most appropriate combination and duration of treatment.

How Does Herceptin 600mg (Trastuzumab) Work?

Herceptin contains trastuzumab, a monoclonal antibody that targets HER2.

HER2 is a receptor protein located on the surface of cells. Some cancers produce excessive amounts of HER2, which can stimulate pathways involved in cell growth and proliferation.

Trastuzumab binds to the HER2 receptor and interferes with HER2 signaling. It may also promote antibody-dependent cellular cytotoxicity (ADCC), allowing immune cells to recognize and attack HER2-expressing cancer cells.

Through these mechanisms, trastuzumab can help inhibit the growth of HER2-positive cancer cells.

HER2 Testing Before Herceptin Treatment

Herceptin is intended for patients whose tumors meet the appropriate criteria for HER2-targeted therapy.

Doctors may use laboratory tests such as:

• Immunohistochemistry (IHC)
• In situ hybridization (ISH)
• Other validated HER2 testing methods

HER2 testing helps determine whether trastuzumab is appropriate for a particular patient.

Herceptin 600mg Dose and Administration

The Herceptin 600mg formulation is administered subcutaneously.

The 600mg dose is generally administered at a fixed dose rather than calculated according to body weight. For the subcutaneous formulation, the usual treatment interval is once every 3 weeks, according to the approved prescribing information and the patient’s treatment plan.

The injection is administered into the subcutaneous tissue of the thigh by a healthcare professional. The injection site may be alternated between the left and right thigh.

Herceptin 600mg should not be administered intravenously. The 600mg subcutaneous formulation is specifically designed for subcutaneous administration.

Patients should not attempt to administer Herceptin themselves unless specifically instructed and authorized by their healthcare professional.

Common Side Effects of Herceptin 600mg

Like all medicines, Herceptin may cause side effects. The type and severity of adverse reactions vary between patients.

Common side effects may include:

• Injection-site reactions
• Fatigue
• Weakness
• Fever
• Chills
• Headache
• Nausea
• Vomiting
• Diarrhea
• Joint pain
• Muscle pain
• Cough
• Rash
• Shortness of breath

Injection-site reactions may include redness, swelling, pain or discomfort around the area where the medicine is administered.

Serious Side Effects of Herceptin

Although many patients tolerate trastuzumab treatment, serious adverse reactions can occur.

Heart Problems

One of the most important risks associated with trastuzumab is cardiac dysfunction, including decreased left ventricular ejection fraction and congestive heart failure.

Heart function may be assessed before treatment and periodically during therapy.

Contact your healthcare provider promptly if you develop:

• New or worsening shortness of breath
• Swelling of the feet or ankles
• Unusual fatigue
• Rapid or irregular heartbeat
• Sudden weight gain

Severe Infusion or Administration-Related Reactions

Trastuzumab can cause administration-related reactions. Symptoms may include:

• Fever
• Chills
• Difficulty breathing
• Wheezing
• Dizziness
• Headache
• Nausea
• Changes in blood pressure

Healthcare professionals monitor patients appropriately and manage serious reactions according to clinical protocols.

Lung Problems

Rare but serious pulmonary complications can occur during trastuzumab treatment. Any new or worsening breathing difficulty should be reported to a healthcare professional promptly.

Precautions Before Using Herceptin 600mg

Before starting treatment with Herceptin, tell your doctor if you have:

• Heart disease
• Previous heart failure
• High blood pressure
• Previous treatment with anthracycline chemotherapy
• Lung disease
• Previous serious reactions to trastuzumab
• Allergies to trastuzumab or related medicines

Tell your healthcare provider about all medicines, supplements and other cancer treatments you are currently receiving.

Herceptin 600mg and Heart Monitoring

Because trastuzumab can affect cardiac function, patients may undergo heart assessments before and during treatment.

Depending on the clinical situation, monitoring may include:

• Echocardiography
• MUGA scan
• Assessment of left ventricular ejection fraction
• Other cardiac evaluations

Patients with pre-existing cardiac disease may require additional monitoring.

Herceptin 600mg During Pregnancy

Herceptin may cause fetal harm and is generally not recommended during pregnancy unless specifically determined by a healthcare professional after careful consideration of the risks and benefits.

Women who can become pregnant should discuss effective contraception with their healthcare provider before and during treatment and for the recommended period after the final dose.

If pregnancy occurs while receiving Herceptin, inform the treating healthcare professional immediately.

Herceptin 600mg and Breastfeeding

Breastfeeding should be discussed with your healthcare provider before starting treatment.

Because trastuzumab is a specialized biological medicine, your doctor will advise whether breastfeeding should be discontinued during treatment and for the recommended period after treatment.

Herceptin 600mg Storage

Herceptin 600mg is a temperature-sensitive biological medicine and must be stored according to the manufacturer’s approved storage conditions.

The product should generally be stored refrigerated and protected from light. Do not freeze or shake the medicine.

Storage and handling should be performed by qualified healthcare professionals or authorized pharmaceutical personnel.

Herceptin 600mg Injection Price in Pakistan

The Herceptin 600mg Injection price in Pakistan may vary depending on availability, supplier, import costs, exchange rates and current market conditions.

For the latest Herceptin 600mg price in Pakistan, customers can contact MedicineWalyDost.com to check current availability and pricing.

Because specialized oncology medicine prices can change, customers should confirm the current price before ordering.

Why Choose Herceptin 600mg Injection?

Herceptin 600mg contains trastuzumab, a targeted HER2 therapy widely used in appropriate patients with HER2-positive breast cancer.

The 600mg subcutaneous formulation offers a fixed-dose administration option that can be delivered in a relatively short administration period compared with traditional intravenous infusion, when clinically appropriate.

The product listed here is manufactured by Roche and supplied in a pack size of 1 injection.

Herceptin should only be used after appropriate HER2 testing and under the supervision of an experienced oncologist or qualified healthcare professional.

Frequently Asked Questions About Herceptin 600mg

What is Herceptin 600mg Injection?

Herceptin 600mg Injection is a prescription targeted cancer medicine containing trastuzumab, a monoclonal antibody that targets the HER2 receptor.

What is the generic name of Herceptin 600mg?

The generic name is trastuzumab.

Who manufactures Herceptin 600mg?

The manufacturer of the product listed here is Roche.

What is the pack size of Herceptin 600mg?

The pack size is 1 injection.

How is Herceptin 600mg administered?

The 600mg formulation is administered as a subcutaneous injection, generally into the thigh, by a qualified healthcare professional.

How often is Herceptin 600mg given?

The 600mg subcutaneous formulation is generally administered once every 3 weeks, according to the approved treatment regimen.

Is Herceptin 600mg chemotherapy?

No. Herceptin is a targeted biological therapy and monoclonal antibody. It specifically targets HER2 and may be used together with chemotherapy depending on the patient’s treatment plan.

What is Herceptin 600mg used for?

Herceptin 600mg is primarily used as part of treatment for selected HER2-positive breast cancer patients and other approved HER2-positive indications where the subcutaneous formulation is appropriate.

Does a patient need HER2 testing before Herceptin?

Yes. HER2 testing is an important part of determining whether trastuzumab treatment is appropriate.

Can Herceptin 600mg be purchased without a prescription?

Herceptin is a specialized prescription oncology medicine and should only be used under the supervision of an oncologist or qualified healthcare professional.

Order Herceptin 600mg Injection in Pakistan

Looking for Herceptin 600mg Injection (Trastuzumab) by Roche in Pakistan?

MedicineWalyDost.com provides access to specialized prescription medicines and oncology products. Contact us to check the latest Herceptin 600mg price, availability and ordering information.

Before ordering, confirm the brand, strength, active ingredient, manufacturer, pack size and prescription requirements with your doctor or pharmacist.

Order Herceptin 600mg Injection from MedicineWalyDost.com and contact us today for current availability and pricing.

Important Medical Disclaimer

Herceptin 600mg Injection is a prescription cancer medicine. This product description is intended for educational and e-commerce purposes only and does not replace professional medical advice. Herceptin should be prescribed and administered by a qualified healthcare professional. Do not change the dose, treatment schedule or route of administration without medical advice.